Webinars and Sponsored Roundtables — Register Now
Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Product Spotlight
QuidelOrtho
| Company | QuidelOrtho |
|---|---|
| Name of instrument | Vitros XT 3400 Chemistry Systems |
| City, State | Raritan, NJ |
| Phone | 800-828-6316 |
| Website | |
| Type of instrument | chemistry |
| Operational type/Model type | batch, random access, continuous random access, discrete/ floor standing |
| List price/First year sold in U.S. | —/2019 |
| Targeted hospital bed size/Targeted | —/annual: 50, 000–4 million |
| Company manufactures instrument | no (manufactured by JABIL; also sold by Cardinal, McKesson, more) |
| Other models in this family of analyzers | Vitros 4600 Chemistry System, Vitros 350 Chemistry System |
| No. of units in clinical use in U.S./Outside U.S. (countries) | > 140/> 225 (North, Central, and South Americas, more) |
| Dimensions (H × W × D)/Instrument footprint | 53 × 58 × 34 in./— |
| Weight empty/Weight fully loaded | 1, 150 lbs./— |
| No. of different measured assays onboard simultaneously | 89 (89 can be run and calibrated at one time) |
| No. of user-definable (open chemistry) channels | — |
| Test throughput per hour/Assay run time | 1, 130/2.5–9 min. (avg. 5 min.) |
| No. of direct ion-selective electrode channels | 3 |
| Detection methods | photometry, potentiometry, turbidimetry |
| • Ion-selective electrode | 5 min./126 specimens per hr. |
| • Basic metabolic panel | 6 min./95 specimens per hr. |
| • Complete metabolic panel | 7.5 min./74 specimens per hr. |
| Typical time delay from ordering stat test until aspiration of sample | 1 min. |
| Fully automated microplate immunoassay system | — |
| Methodologies supported | — |
| Separation methodologies | — |
| Stat time until completion of a ß-hCG test | — |
| Stat time until completion of a cTn test | — |
| • Typical time delay from test order to aspiration of sample | — |
| Approximate No. of tests per reagent set/Reagent type | 18–120/self-contained single use |
| Reagents refrigerated onboard/Reagents ready to use | yes (10°C)/yes |
| Reagent lot tracking/Reagent inventory | yes/yes |
| Reagent form/Reagents barcoded | dry chemistry (closed reagent system)/yes |
| Separate reagent pack for each specimen/for each test run | no/no |
| Walkaway capability/Walkaway duration | yes/— |
| Design of sample-handling system | universal sample tray, continuous load and unload, circular routine sample center |
| Uses washable cuvettes/Uses disposable cuvettes | no/no |
| Min.–max. sample volume that can be aspirated at one time | 2–200 µL |
| Min. reaction volume/Min. specimen volume/Min. dead volume | —/2.5 µL/35 µL |
| Dedicated pediatric sample cup | yes (dead volume: 35 µL) |
| Primary tube sampling | yes |
| Accommodates most standard tube sizes/Accepts nonstandard tube sizes | yes/yes (micro sample cups, micro collection containers, 10.25 × 45 mm, 12 × 75 mm, 12 × 100 mm, 13 × 75 mm, more) |
| Pierces caps on primary tubes | no |
| Protects against probe collision | yes |
| Detects clots/liquid level/short sample | yes/yes/yes |
| Detection or quantitation for hemolysis, icterus, lipemia, clots | detection for clots; detection and quantitation for hemolysis, icterus, lipemia |
| Dilutes patient samples onboard/Susceptibility to carryover | yes/0 |
| Automatic rerun capability | yes |
| Sample volume can be concentrated to rerun out-of-linear-range low results | yes |
| Analyzer requires dedicated water supply | no |
| Autocalibration/Multipoint calibration supported | no (calibrants are not stored onboard)/yes (recommended avg. frequency: 6 months or lot change) |
| Typical calibration frequency for ISE/therapeutic drugs/drugs of abuse/general chemistries/immunoassays | 6 months/6 months/6 months/6 months or lot change for most chemistry assays/— |
| Automatic programmable start/Automatic programmable shutdown | no/no |
| Onboard real-time QC/Onboard software capability to review QC | yes/yes |
| Supports multiple QC lot numbers per analyte | yes |
| Waste management | manually by user |
| Sample barcode-reading capability/Autodiscrimination | yes (Interleaved 2 of 5, UPC, Codabar, Code 39, Code 128, ISBT 128)/yes |
| Lab can control analyzer from remote computer | no |
| Instrument can diagnose its own malfunctions | yes (operator intervention required to order parts) |
| System malfunctions can be diagnosed via remote monitoring | yes |
| UPS backup power supply | yes |
| Data-management capability/LIS or EHR systems interfaced | onboard/— |
| LIS interface provided/Bidirectional interface capability | yes (included in instrument price)/yes (broadcast download and host query) |
| Modem servicing provided/Service engineer on-site response time | yes/4 hrs. |
| Mean time between failures | — (displays error codes for troubleshooting) |
| Average scheduled maintenance time by lab personnel | daily: ~7 min. (incl. automated); weekly: ~10 min.; monthly: ~10 min. |
| Maintenance records kept onboard for user/vendor | yes (includes audit trail of who replaced parts)/yes (includes audit trail of who replaced parts) |
| Maintenance training demonstration module onboard | no |
| Training included with purchase/Avg. time for basic user training | yes (1 training slot)/4 days (at customer site) |
| Advanced operator training/Extra charge for follow-up or advanced training | yes (at customer site)/yes |
| Warranty provided/Cost of annual service contract (24 h/7 d) | yes (1 year)/— |
| Distinguishing features (supplied by company) | XT Microslide performs two tests on one slide, which doubles testing output, increases productivity, and fulfills more requests from difficult draws; designed to use single-patient consumables without the need for water, eliminating risk of carryover; MicroSensor technology automates detection of HIL interferences |